These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3032382)
1. Effects of a specific bradycardic agent (AQ-A39) and verapamil on beta-adrenergic responses in isolated guinea pig atria. Siegl PK; Morgan G Can J Physiol Pharmacol; 1987 Feb; 65(2):146-51. PubMed ID: 3032382 [TBL] [Abstract][Full Text] [Related]
2. Influence of AQ-A39, a bradycardic agent, on cardiovascular responses to isoproterenol in the anesthetized dog. Wenger HC; Siegl PK J Cardiovasc Pharmacol; 1987 Feb; 9(2):246-53. PubMed ID: 2436007 [TBL] [Abstract][Full Text] [Related]
3. Actions of alinidine and AQ-A 39 on rate and contractility of guinea pig atria during beta-adrenoceptor stimulation. Lillie C; Kobinger W J Cardiovasc Pharmacol; 1983; 5(6):1048-51. PubMed ID: 6196553 [TBL] [Abstract][Full Text] [Related]
4. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart. Kobinger W; Lillie C Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205 [TBL] [Abstract][Full Text] [Related]
5. Bradycardic effects of AQ-A 39 (falipamil) in situ and in isolated, blood-perfused dog hearts. Comparison with alinidine and verapamil. Ogiwara Y; Furukawa Y; Akahane K; Haniuda M; Chiba S Jpn Heart J; 1988 Nov; 29(6):849-61. PubMed ID: 3241338 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent". Kobinger W; Lillie C Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent. Dämmgen J; Kadatz R; Diederen W Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs. Gross GJ; Daemmgen JW J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124 [TBL] [Abstract][Full Text] [Related]
9. Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs. Gross GJ; Daemmgen JW J Cardiovasc Pharmacol; 1987 Jul; 10(1):123-7. PubMed ID: 2441148 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions. Lillie C; Kobinger W Eur J Pharmacol; 1983 Jan; 87(1):25-33. PubMed ID: 6840187 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular responses to increasing plasma concentrations of AQ-A 39 Cl, a new compound with negative chronotropic effects. Verdouw PD; Bom HP; Bijleveld RE Arzneimittelforschung; 1983; 33(5):702-6. PubMed ID: 6683548 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions. Hattori Y; Sakuma I; Nakao Y; Kanno M J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870 [TBL] [Abstract][Full Text] [Related]
13. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations. Kawada M; Satoh K; Taira N J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121 [TBL] [Abstract][Full Text] [Related]
14. Effect of zatebradine on contractility, relaxation and coronary blood flow. Breall JA; Watanabe J; Grossman W J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013 [TBL] [Abstract][Full Text] [Related]
15. Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria. Lillie C; Kobinger W J Cardiovasc Pharmacol; 1986; 8(4):791-7. PubMed ID: 2427820 [TBL] [Abstract][Full Text] [Related]
16. Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration. Lillie C; Kobinger W Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):210-3. PubMed ID: 6527706 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological studies on effects of AQ-A 39 in the isolated guinea pig heart and myocardial preparations. Hohnloser S; Weirich J; Homburger H; Antoni H Arzneimittelforschung; 1982; 32(7):730-4. PubMed ID: 6889873 [TBL] [Abstract][Full Text] [Related]
18. Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers. Lillie C; Kobinger W Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):331-3. PubMed ID: 3587375 [TBL] [Abstract][Full Text] [Related]
19. Naloxone potentiates inotropic but not chronotropic effects of isoproterenol in vitro. Lechner RB Circ Shock; 1993 Mar; 39(3):226-30. PubMed ID: 8453747 [TBL] [Abstract][Full Text] [Related]
20. Influences of extracellular calcium ions, verapamil, and calcium antagonistic cations on the positive inotropic effects mediated by alpha- and beta-adrenoceptors in the left atria of rats. Hattori Y; Kanno M Gen Pharmacol; 1984; 15(2):91-7. PubMed ID: 6325289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]